These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13319156)

  • 1. A note on the metabolism of lysergic acid by Claviceps purpurea (Fries) Tulasne.
    GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1956 Jun; 45(6):428-30. PubMed ID: 13319156
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid.
    Jastrzębski MK; Kaczor AA; Wróbel TM
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on the biosynthesis of clavine alkaloids in Claviceps purpurea strain 15B.
    BRADY LR; TYLER VE
    J Am Pharm Assoc Am Pharm Assoc; 1960 May; 49():332. PubMed ID: 13849150
    [No Abstract]   [Full Text] [Related]  

  • 4. The parasitic growth of Claviceps purpurea (Fries) Tulasne on rye and its relation to alkaloid formation.
    RAMSTAD E; GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):741-3. PubMed ID: 13278240
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of certain chemicals on the growth and alkaloid formation of Claviceps purpurea (Fries) Tulasne in artificial culture.
    GJERSTAD G; RAMSTAD E
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):736-40. PubMed ID: 13278239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contributions to the quantitative study of lysergic alkaloid distribution in the sclerotia of Claviceps purpurea].
    Ioachimescu-Angelescu E; Gruia S; Bojor O
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(3):499-502. PubMed ID: 16296516
    [No Abstract]   [Full Text] [Related]  

  • 7. FORMATION OF A LYSERGIC ACID DERIVATIVE DURING THE PARASITIC DEVELOPMENT OF A STRAIN OF CLAVICEPS PASPALI STEVENS AND HALL.
    BIANCHI P; CHAIN EB; MANTLE PG; TONOLO A
    Nature; 1964 Apr; 202():312-3. PubMed ID: 14167810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of species and strains of the ergot Claviceps purpurea Tulasne].
    KYBAL J; BREJCHA V
    Pharmazie; 1955 Dec; 10(12):752-5. PubMed ID: 13310248
    [No Abstract]   [Full Text] [Related]  

  • 9. The culture of Claviceps purpurea. II. Preliminary metabolism studies.
    PAUL AG; KELLEHER WJ; SCHWARTING AE
    J Am Pharm Assoc Am Pharm Assoc; 1954 Apr; 43(4):205-7. PubMed ID: 13151978
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of phosphate metabolism of Claviceps purpurea (Fr.) Tul. II. Relationship between nucleic acids synthesis and ergot alkaloid production.
    de WAART
    Can J Microbiol; 1961 Dec; 7():883-8. PubMed ID: 14004189
    [No Abstract]   [Full Text] [Related]  

  • 11. D-lysergic acid-activating enzyme from the ergot fungus Claviceps purpurea.
    Keller U; Zocher R; Krengel U; Kleinkauf H
    Biochem J; 1984 Mar; 218(3):857-62. PubMed ID: 6326747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acid.
    Thamhesl M; Apfelthaler E; Schwartz-Zimmermann HE; Kunz-Vekiru E; Krska R; Kneifel W; Schatzmayr G; Moll WD
    BMC Microbiol; 2015 Mar; 15():73. PubMed ID: 25887091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states].
    SOLMS H
    Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preservation of Claviceps purpurea, the producer of peptide ergot alkaloids, by the method of freeze drying].
    Ustiuzhanina SV; Sarkisova MA; Gorin SE
    Antibiot Khimioter; 1991 Feb; 36(2):6-8. PubMed ID: 2025122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and analysis of the ergopeptine assembly system in the ergot fungus Claviceps purpurea.
    Correia T; Grammel N; Ortel I; Keller U; Tudzynski P
    Chem Biol; 2003 Dec; 10(12):1281-92. PubMed ID: 14700635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric course of the N-methylation in the biosynthesis of ergot alkaloids by Claviceps purpurea.
    Gröger D; Gröger L; D'Amico D; He MX; Floss HG
    J Basic Microbiol; 1991; 31(2):121-5. PubMed ID: 1880714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ergot alkaloid gene cluster in Claviceps purpurea: extension of the cluster sequence and intra species evolution.
    Haarmann T; Machado C; Lübbe Y; Correia T; Schardl CL; Panaccione DG; Tudzynski P
    Phytochemistry; 2005 Jun; 66(11):1312-20. PubMed ID: 15904941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-lysergic acid activation and cell-free synthesis of D-lysergyl peptides in enzyme fractions from the ergot fungus Claviceps purpurea.
    Keller U; Han M; Stöffler-Meilicke M
    Biochemistry; 1988 Aug; 27(16):6164-70. PubMed ID: 2847788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the composition of a nutrient medium on growth and synthesis of ergot alkaloids by Claviceps purpurea in the saprotrophic culture].
    Sarkisova MA; Fishman VM
    Antibiot Khimioter; 1991 Dec; 36(12):8-10. PubMed ID: 1814274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergot alkaloids. II. On the spectrum of ergot alkaloids contained in the sclerotia of Claviceps purpurea (Fr.) Tul. and Claviceps paspali Stev. et Hall.
    Kleinerová E; Kybal J
    Folia Microbiol (Praha); 1969; 14(6):602-4. PubMed ID: 5372898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.